4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-1-acetamide, 95.0%, 5g

5-chloro-7-methyl-2,3-dihydro-1,3-benzoxazole-2-thione, 95%, 2.5g

3-(1-(tert-Butoxycarbonyl)azetidin-3-yl)propanoic acid, 98%, 1g

(11bR)-N,N-Bis((S)-1-phenylethyl)-8,9,10,11,12,13,14,15-octahydrodinaphtho[2,1-d:1',2'-f][1,3,2]di-oxaphosphepin-4-amine, 97%, 250mg

Hydroxyacetone (stabilized with Na2CO3)>90.0%(GC)500mL

1-aminocycloheptanecarboxylic acid, 95.0%, 10g

2-Bromo-1-(m-tolyl)propan-1-one, 95.0%, 1g

6-Fluoro-2,3-dimethoxybenzaldehyde, 98%, 1g

Recipientes de esterilización para pipetas, Gesch. para pipetas 315-385 mm 1 ud

5-Methyl-4H-1,2,4-triazol-3-amine hydrochloride, 95.0%, 250mg

Bis[3-(triethoxysilyl)propyl]amine>95.0%(GC)25g

6-Chloroquinazoline-2,4(1H,3H)-dione, 95.0%, 5g

4-(2-methoxyphenyl)-4-oxobutyronitrile, 97.0%, 1g